Cargando…

Determinants of Levodopa Responsiveness in Patients with Vascular Parkinsonism

INTRODUCTION: Vascular Parkinsonism (VaP) is characterized by symmetric, predominantly lower limb bradykinesia and rigidity and no significant improvement with levodopa. We aimed to describe the clinical and radiological features of patients with VaP and the factors that determine levodopa responsiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Goyal, Sheetal, Kamble, Nitish, Mukheem Mudabbir, M A, Bhattacharya, Amitabh, Yadav, Ravi, Pal, Pramod Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996467/
https://www.ncbi.nlm.nih.gov/pubmed/36911450
http://dx.doi.org/10.4103/aian.aian_100_22
_version_ 1784903048987934720
author Goyal, Sheetal
Kamble, Nitish
Mukheem Mudabbir, M A
Bhattacharya, Amitabh
Yadav, Ravi
Pal, Pramod Kumar
author_facet Goyal, Sheetal
Kamble, Nitish
Mukheem Mudabbir, M A
Bhattacharya, Amitabh
Yadav, Ravi
Pal, Pramod Kumar
author_sort Goyal, Sheetal
collection PubMed
description INTRODUCTION: Vascular Parkinsonism (VaP) is characterized by symmetric, predominantly lower limb bradykinesia and rigidity and no significant improvement with levodopa. We aimed to describe the clinical and radiological features of patients with VaP and the factors that determine levodopa responsiveness. METHODS: This is a retrospective chart review of patients with VaP. The study included 44 patients (36 men) with VaP. The diagnosis was based on Zijlman's criteria. Demographic and clinical details were recorded from the case files. MRI data were available for all the patients. However, the motor severity scores assessed in the OFF and ON states using the unified Parkinson's disease rating scale (UPDRS) part III were available for 17 patients only. Based on the Magnetic Resonance Imaging (MRI) finds, patients were categorized into isolated periventricular ischemic (PVI) changes, isolated basal ganglia (BG)/thalamic infarcts, and both combined. RESULTS: The mean age at the diagnosis was 65.2 ± 7.4 years. Further, the age at the onset of symptoms was 61.8 ± 8.1 years and the total disease duration was 3.5 ± 2.5 years. Hypertension was the most common risk factor and was observed in 88.6% of patients. Symmetrical lower body parkinsonism was observed in 88.6%. The mean UPDRS part III OFF score was 33.76 ± 12.7 and ON score was 30 ± 13.98. PVI changes were the most common MRI abnormality detected. Patients with isolated BG/thalamic infarcts had better mini-mental status examination scores and better levodopa responsiveness compared to other groups. CONCLUSIONS: Hypertension was the most common risk factor seen in patients with VaP. Those with isolated BG/thalamus infarcts demonstrated better levodopa responsiveness.
format Online
Article
Text
id pubmed-9996467
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-99964672023-03-10 Determinants of Levodopa Responsiveness in Patients with Vascular Parkinsonism Goyal, Sheetal Kamble, Nitish Mukheem Mudabbir, M A Bhattacharya, Amitabh Yadav, Ravi Pal, Pramod Kumar Ann Indian Acad Neurol Original Article INTRODUCTION: Vascular Parkinsonism (VaP) is characterized by symmetric, predominantly lower limb bradykinesia and rigidity and no significant improvement with levodopa. We aimed to describe the clinical and radiological features of patients with VaP and the factors that determine levodopa responsiveness. METHODS: This is a retrospective chart review of patients with VaP. The study included 44 patients (36 men) with VaP. The diagnosis was based on Zijlman's criteria. Demographic and clinical details were recorded from the case files. MRI data were available for all the patients. However, the motor severity scores assessed in the OFF and ON states using the unified Parkinson's disease rating scale (UPDRS) part III were available for 17 patients only. Based on the Magnetic Resonance Imaging (MRI) finds, patients were categorized into isolated periventricular ischemic (PVI) changes, isolated basal ganglia (BG)/thalamic infarcts, and both combined. RESULTS: The mean age at the diagnosis was 65.2 ± 7.4 years. Further, the age at the onset of symptoms was 61.8 ± 8.1 years and the total disease duration was 3.5 ± 2.5 years. Hypertension was the most common risk factor and was observed in 88.6% of patients. Symmetrical lower body parkinsonism was observed in 88.6%. The mean UPDRS part III OFF score was 33.76 ± 12.7 and ON score was 30 ± 13.98. PVI changes were the most common MRI abnormality detected. Patients with isolated BG/thalamic infarcts had better mini-mental status examination scores and better levodopa responsiveness compared to other groups. CONCLUSIONS: Hypertension was the most common risk factor seen in patients with VaP. Those with isolated BG/thalamus infarcts demonstrated better levodopa responsiveness. Wolters Kluwer - Medknow 2022 2022-11-21 /pmc/articles/PMC9996467/ /pubmed/36911450 http://dx.doi.org/10.4103/aian.aian_100_22 Text en Copyright: © 2022 Annals of Indian Academy of Neurology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Goyal, Sheetal
Kamble, Nitish
Mukheem Mudabbir, M A
Bhattacharya, Amitabh
Yadav, Ravi
Pal, Pramod Kumar
Determinants of Levodopa Responsiveness in Patients with Vascular Parkinsonism
title Determinants of Levodopa Responsiveness in Patients with Vascular Parkinsonism
title_full Determinants of Levodopa Responsiveness in Patients with Vascular Parkinsonism
title_fullStr Determinants of Levodopa Responsiveness in Patients with Vascular Parkinsonism
title_full_unstemmed Determinants of Levodopa Responsiveness in Patients with Vascular Parkinsonism
title_short Determinants of Levodopa Responsiveness in Patients with Vascular Parkinsonism
title_sort determinants of levodopa responsiveness in patients with vascular parkinsonism
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996467/
https://www.ncbi.nlm.nih.gov/pubmed/36911450
http://dx.doi.org/10.4103/aian.aian_100_22
work_keys_str_mv AT goyalsheetal determinantsoflevodoparesponsivenessinpatientswithvascularparkinsonism
AT kamblenitish determinantsoflevodoparesponsivenessinpatientswithvascularparkinsonism
AT mukheemmudabbirma determinantsoflevodoparesponsivenessinpatientswithvascularparkinsonism
AT bhattacharyaamitabh determinantsoflevodoparesponsivenessinpatientswithvascularparkinsonism
AT yadavravi determinantsoflevodoparesponsivenessinpatientswithvascularparkinsonism
AT palpramodkumar determinantsoflevodoparesponsivenessinpatientswithvascularparkinsonism